Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline Chemoprophylaxis for Leptospirosis in Thailand
NCT07865156Phase 4Not yet recruiting
- Sponsor
- Chulalongkorn University
- Start
- Nov 2026
- Primary completion
- Dec 2026
01
Overview
Phase 4, randomised trial in leptospirosis comparing Doxycycline 200 mg weekly dose with Placebo (2 arms). Primary endpoint: Incidence of Leptospira infection at 1 month. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
doxycycline
03
Conditions
leptospirosis
Beyond the preview
Go deeper on NCT07865156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07865156.